Nine genes including NSD2, MLL2, and JARID1C act as drivers in only one to three tumor types, and the rest nine genes including DNMT3A, EZH2, and SET2 drive 5–18 malignancies (Fig. 4a). This evidence concerns the gene EZH2 and neoplasm.